Business Intelligence

To be successful in the Medicare Shared Savings Program, a provider has to participate in value-based care across the health system. That's according to the CMO of one that earned the third largest total savings in its third year in the program.

Report describes steps states can take to address a number of drug-coverage issues in the commercial insurance market.

Responding to pressure from lawmakers and the public, Mylan Pharmaceutical is expanding existing programs to make its EpiPen emergency allergy treatments more affordable.

Johns Hopkins Medicine has launched the Johns Hopkins Wilmer Zika Center, where medical professionals focus on caring for patients with the Zika virus. The center is touted as the first multidisciplinary Zika center in the world.

Orlando Health and Florida Hospital will waive $5.5 million in costs and continue to help victims with financial assistance for follow-up care.

Any premium increases would be offset by comparative shopping and tax credits, says Department Health and Human Services.

Lawmakers are imploring Mylan Pharmaceutical, the manufacturer of EpiPens, to scale back price increases that have seen the cost of the life-saving emergency allergy treatment swell from $100 to $600 per package, according to published reports.

If the poorest areas utilized healthcare at the rate of the most affluent, overall utilization and spending could be as much as 30 percent less, according to a new book published by the late Richard Cooper, MD.

Aetna said it has already announced plans to divest much of its Medicare Advantage business.

In a recent poll of healthcare professionals, Hillary Clinton is the preferred presidential candidate among physician practice professionals, with 48 percent of respondents saying she would "most benefit" their practices.